-
Maxim: Nothing 'Nefarious' At Anavex Life Sciences
Tuesday, December 29, 2015 - 4:32pm | 288Read More...The investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) on whether its officers or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 is seen as nothing "nefarious" by Maxim Group. The stock dropped 11 percent in Tuesday's session,...
-
Analyst: Chipotle Can Fall To $400s
Tuesday, December 8, 2015 - 11:00am | 315Read More...Chipotle Mexican Grill, Inc. (NYSE: CMG) shares are down 28 percent in the last three months, even after rising past $750 on October 13. Maxim Group maintained a Hold rating on the company, while reducing the price target from $585 to $495. The analyst said that the E. coli outbreak had...
-
Panera The Ultimate Winner From Chipotle's E. Coli Disaster?
Monday, November 23, 2015 - 10:17am | 368Read More...Panera Bread Co (NASDAQ: PNRA) shares are down 7 percent year-to-date, even after hitting a high of $197.86 on October 7. Maxim Group’s Stephen Anderson upgraded the rating on the company from Hold to Buy, while raising the price target from $208 to $210. Panera is expected to gain...
-
Maxim Maintains Hold Rating On Chipotle Ahead Of Q3 Results
Monday, October 19, 2015 - 1:18pm | 318Read More...Chipotle Mexican Grill, Inc. (NYSE: CMG) shares have been volatile in 2015 and are up 4 percent year-to-date. Maxim Group’s Stephen Anderson maintained a Hold rating on the company, with a price target of $810. Chipotle is poised to benefit from the return of pork in the form of lower food...
-
Maxim Lifts Buffalo Wild Wings To Buy, Maintains $217 Target
Monday, October 19, 2015 - 11:06am | 296Read More...Buffalo Wild Wings (NASDAQ: BWLD) shares have risen steadily since July 24, when they touched a low of $168, and are up 11 percent in the last three months. Maxim Group’s Stephen Anderson upgraded the company from Hold to Buy, while maintaining a price target of $217. Reduced...
-
Why Darden's Turnaround Story Is Now 'More Compelling'
Monday, October 19, 2015 - 10:53am | 331Read More...Darden Restaurants, Inc. (NYSE: DRI) shares are down 10 percent since July 20, after having hit a high of $74.91 on August 5. Maxim Group’s Stephen Anderson upgraded the rating on the company from Hold to Buy, while maintaining the price target at $80. Anderson believes that...
-
Potential B-Dubs Investor? It Might Be Worth Waiting For 'Deeper Pullback'
Friday, September 18, 2015 - 11:17am | 362Read More...Buffalo Wild Wings (NASDAQ: BWLD) shares have gained 24 percent over the past three months, trading above the $200 mark on September 15. Maxim Group’s Stephen Anderson initiated coverage of the company with a Hold rating and a price target of $217. Despite several positives at the...
-
The Best Fast Casual Investment Might Surprise You
Wednesday, August 19, 2015 - 9:13am | 369Read More...Fast casual stocks are becoming more prevalent not just in everyday life, but in the stock market as well. There are now enough publicly-traded names to warrant its grouping as an official sub-sector of the restaurant space. In a report published Wednesday, Maxim Group analyst Stephen Anderson...
-
BioLineRx Investors: Expect 'Pivotal' Data In Next Few Weeks
Thursday, July 16, 2015 - 9:53am | 199Read More...In a report published Thursday, Maxim Group analyst Jason Kolbert maintained a Buy rating on BioLine RX Ltd (NASDAQ: BLRX), with a price target of $8, ahead of the BL-1040 pivotal trial data in Europe, expected in the next few weeks. BL-1040, known as bioabsorbable cardiac matrix or BCM, is "a...
-
Gilead Still A 'Buy' After Harvoni Approval In Japan, Maxim Proclaims
Monday, July 6, 2015 - 10:04am | 238Read More...In a report published Monday, Maxim analyst Jason Kolbert maintained a Buy rating and $127 price target on Gilead Sciences, Inc. (NASDAQ: GILD), while mentioning that Harvoni had received approval in Japan. A majority of the population in Japan is genotype 1, a group for which Harvoni has...
-
Maxim Hikes First Republic Bank Estimates On New Events, Disclosures; Reiterates Buy
Thursday, July 2, 2015 - 9:34am | 147Read More...In a report published Thursday, Maxim Group analyst Michael Diana maintained a Buy rating on First Republic Bank (NYSE: FRC), with a price target of $70. First Republic Bank issued $100 million of preferred stock and received a $9.1 million special dividend from the Federal Home Loan Bank of San...
-
Maxim Group Initiates Juno Therapeutics With Buy
Thursday, June 18, 2015 - 8:35am | 33Read More...Maxim Group initiated coverage on Juno Therapeutics Inc (NASDAQ: JUNO) with a Buy rating. Juno Therapeutics' shares rose 1.79 percent to $52.25 in pre-market trading.
-
Maxim Group Initiates Astec Industries With Buy
Wednesday, June 17, 2015 - 8:01am | 64Read More...Maxim Group initiated coverage on Astec Industries, Inc. (NASDAQ: ASTE) with a Buy rating. The target price for Astec Industries is set to $52. Astec Industries shares have dropped 2.90 percent over the past 52 weeks, while the S&P 500 index has surged 7.12 percent in the same period. Astec...
-
Maxim Group Downgrades Profire Energy To Hold
Tuesday, June 16, 2015 - 9:24am | 50Read More...Maxim Group downgraded Profire Energy, Inc. (NASDAQ: PFIE) from Buy to Hold. Profire Energy shares have dropped 74.16 percent over the past 52 weeks, while the S&P 500 index has surged 7.33 percent in the same period. Profire Energy shares closed at $1.30 yesterday.
-
Maxim Group Downgrades Tekmira Pharmaceuticals To Hold
Tuesday, June 16, 2015 - 9:18am | 63Read More...Analysts at Maxim Group downgraded Tekmira Pharmaceuticals Corp (NASDAQ: TKMR) from Buy to Hold. The price target for Tekmira Pharmaceuticals has been lowered from $27.00 to $14.00. Tekmira Pharmaceuticals shares have gained 10.51 percent over the past 52 weeks, while the S&P 500 index has...
